Otsuka Pharmaceutical is broadening its scope in rare disease, striking a deal to acquire Jnana Therapeutics and its lead drug candidate, a small molecule on track for pivotal testing in a metabolic ...

The millions of people who regularly suffer from heartburn now have a new FDA-approved treatment option, a Phathom Pharmaceuticals drug with a different mechanism of action than older medications that ...

Health informatics leaders at NYU Langone Health think fully autonomous clinical AI is coming in the next five years or so, ...

On Wednesday, the Centers for Medicare & Medicaid Services launched a new initiative in tandem with the White House and HHS aimed at creating a more patient-centric healthcare ecosystem. As part of ...

Eli Lilly’s engineered peptide drugs Mounjaro and Zepbound are once-weekly injectable products, formulations that are expensive to manufacture and burdensome to patients who dislike needles. Lilly ...

A Boehringer Ingelheim drug now has FDA approval as an earlier treatment for lung cancers expressing a certain genetic signature, a regulatory decision handed out under the agency’s new pilot program ...

Galapagos believed so strongly in its work developing new cancer cell therapies that it pinned its future on them. This past winter, the Belgian drugmaker unveiled a plan to spin out the rest of the ...

The FDA turned down an Intercept Pharmaceuticals drug application for the fatty liver disease NASH, a decision that comes nearly three years after the regulator first rejected the molecule. The agency ...

Positive Development, a developmental therapy provider for children with autism, announced Wednesday that it raised $51.5 million in Series C funding. The McLean, Virginia-based company’s model is ...

Johnson & Johnson is boosting its immunology and inflammation drug pipeline with the acquisition of Proteologix, a startup whose most advanced program is ready for Phase 1 testing in asthma and atopic ...

For healthcare leaders evaluating procurement options or clinicians recommending at-home care, selecting the right gel pack supplier requires careful evaluation of durability, temperature retention, ...

Gilead Sciences is expanding its cell therapy pipeline and technological capabilities through the $7.8 billion acquisition of Arcellx, its partner in the development of a multiple myeloma treatment ...